
Publication
Recent developments on AI in federal government institutions
Canada’s proposed artificial intelligence (AI) legislation, the Artificial Intelligence and Data Act, died on the Order Paper earlier this year when Parliament was prorogued.
Global | Publication | June 2018
In this edition of Insurance Focus, we look at some challenging new areas of law. How can firms ensure that their application of artificial intelligence doesn’t harm customers and impact the firm’s reputation? We look at a best-practice model for AI governance in insurance models.
D&O is on the rise globally as attitudes change in relation to executive accountability. Consequently, regulators and shareholders are increasingly incentivised to tackle corporate misconduct. We consider how the regulator in Australia is now getting tough on corporate crime.
As cannabis usage becomes legalised in Canada, we take a practical look at the implications for the insurance industry of the “green rush” following legalisation.
We include a summary of the recent VAT decision in relation to a Gibraltar insurance company and its affiliate in the UK. In addition, from Shanghai we consider new investment rules in the insurance sector introduced by the China Insurance Regulatory Commission.
In our case notes section we consider whether a Queen’s Counsel with over 10 years’ experience had sufficient knowledge of insurance to act as arbitrator and the importance of looking to the “root of the transaction” when interpreting contracts.
We also include our regular feature of interesting legal and regulatory updates from across our offices.
We hope you enjoy reading this edition of Insurance Focus.
Publication
Canada’s proposed artificial intelligence (AI) legislation, the Artificial Intelligence and Data Act, died on the Order Paper earlier this year when Parliament was prorogued.
Publication
The US Corporate Transparency Act (CTA) is a law that requires companies to disclose information on their beneficial owners.
Publication
Health Canada has published a Notice of Intent to publish a ministerial order to exempt natural health products (NHPs) licensed between June 21, 2025, and June 21, 2028, from labelling requirements that are set to come into force this summer under the Natural Health Products Regulations (NHPR).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025